Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting

Acta Diabetologica

27 March Mar 2018 7 months ago
  • Genovese S

There is an unmet need among healthcare providers to identify subgroups of patients with type 2 diabetes who are most likely to respond to treatment.
Glycaemic response to liraglutide is largely driven by baseline HbA1c levels and, to a lesser extent, by diabetes duration.

Reference
Simioni N, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Lapolla A, Bette C, Rossi MC; ReaL (NN2211-4118) Study Group*. Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting. Acta Diabetol 2018 Mar 12. doi: 10.1007/s00592-018-1124-0. [Epub ahead of print]

Go to PubMed